Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,763 | 262 | 99.7% |
| Entertainment | $12.78 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $973.06 | 77 | $0 (2024) |
| GlaxoSmithKline, LLC. | $359.02 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $320.12 | 23 | $0 (2024) |
| PFIZER INC. | $184.02 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $182.25 | 12 | $0 (2023) |
| ABBVIE INC. | $153.25 | 10 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $140.43 | 11 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $139.60 | 10 | $0 (2024) |
| Allergan, Inc. | $125.92 | 10 | $0 (2020) |
| IDORSIA PHARMACEUTICALS US INC | $103.12 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $519.07 | 33 | Novo Nordisk Inc ($183.49) |
| 2023 | $445.89 | 28 | Novo Nordisk Inc ($149.45) |
| 2022 | $558.49 | 38 | Novo Nordisk Inc ($169.67) |
| 2021 | $457.69 | 27 | GlaxoSmithKline, LLC. ($82.61) |
| 2020 | $471.44 | 32 | Novo Nordisk Inc ($89.56) |
| 2019 | $406.68 | 35 | Novo Nordisk Inc ($162.27) |
| 2018 | $514.74 | 41 | Novo Nordisk Inc ($123.08) |
| 2017 | $401.33 | 29 | AstraZeneca Pharmaceuticals LP ($62.89) |
All Payment Transactions
263 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Vaccines | ||||||
| 12/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: Obesity | ||||||
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.01 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: PAIN | ||||||
| 10/29/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.89 | General |
| Category: Obesity | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, BEXSERO | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: VACCINES | ||||||
| 08/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.92 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.66 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $19.94 | General |
| Category: Medical Device | ||||||
| 07/29/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: RESPIRATORY | ||||||
| 07/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Respiratory | ||||||
| 06/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 57 | 3,784 | 12,511 | $562,820 | $168,299 |
| 2022 | 59 | 3,946 | 11,406 | $584,679 | $176,732 |
| 2021 | 58 | 3,912 | 11,814 | $573,388 | $179,824 |
| 2020 | 54 | 4,105 | 12,528 | $586,829 | $169,648 |
All Medicare Procedures & Services
228 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 278 | 473 | $94,600 | $33,301 | 35.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 219 | 219 | $35,040 | $26,731 | 76.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 164 | 310 | $43,400 | $18,008 | 41.5% |
| 77067 | Screening mammography | Office | 2023 | 156 | 156 | $53,820 | $12,549 | 23.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 129 | 129 | $10,320 | $9,476 | 91.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 241 | 389 | $26,452 | $6,403 | 24.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 252 | 436 | $24,416 | $5,694 | 23.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 302 | 670 | $8,984 | $5,324 | 59.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 285 | 512 | $25,600 | $5,268 | 20.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 138 | 140 | $4,900 | $3,953 | 80.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 273 | 479 | $16,286 | $3,638 | 22.3% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 21 | 22 | $17,820 | $3,183 | 17.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 18 | 20 | $6,500 | $2,913 | 44.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 117 | 235 | $11,045 | $2,228 | 20.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 16 | 16 | $2,400 | $2,093 | 87.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 75 | 207 | $7,245 | $1,823 | 25.2% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 19 | 19 | $16,450 | $1,806 | 11.0% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Office | 2023 | 14 | 14 | $4,970 | $1,726 | 34.7% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 27 | 30 | $22,500 | $1,659 | 7.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 56 | 56 | $11,510 | $1,431 | 12.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 43 | 49 | $8,575 | $1,421 | 16.6% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 62 | 62 | $9,300 | $1,296 | 13.9% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 19 | 22 | $13,200 | $1,267 | 9.6% |
| 77066 | Diagnostic mammography of both breasts | Office | 2023 | 15 | 15 | $6,375 | $1,135 | 17.8% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 12 | 14 | $5,250 | $1,016 | 19.3% |
About Dr. Eric Delay, M.D
Dr. Eric Delay, M.D is a Pediatrics healthcare provider based in Morristown, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366460412.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Delay, M.D has received a total of $3,775 in payments from pharmaceutical and medical device companies, with $519.07 received in 2024. These payments were reported across 263 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($3,763).
As a Medicare-enrolled provider, Delay has provided services to 15,747 Medicare beneficiaries, totaling 48,259 services with total Medicare billing of $694,503. Data is available for 4 years (2020–2023), covering 228 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Morristown, TN
- Active Since 07/17/2006
- Last Updated 02/08/2024
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1366460412
Products in Payments
- Ozempic (Drug) $489.53
- FARXIGA (Drug) $196.57
- Rybelsus (Drug) $175.97
- JARDIANCE (Drug) $152.33
- TRELEGY ELLIPTA (Drug) $119.11
- SHINGRIX (Biological) $113.78
- Tresiba (Drug) $111.34
- UBRELVY (Drug) $105.49
- QUVIVIQ (Drug) $103.12
- Victoza (Drug) $98.78
- XARELTO (Drug) $96.54
- ENTRESTO (Drug) $96.02
- Trintellix (Drug) $78.15
- NURTEC ODT (Drug) $72.83
- Vascepa (Drug) $72.43
- Wegovy (Drug) $69.06
- TOUJEO (Drug) $61.23
- Adlarity (Drug) $59.90
- TRULICITY (Drug) $56.79
- NEXLETOL (Drug) $55.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Morristown
Dr. Simona Nativ, Md, MD
Pediatrics — Payments: $7,707
Kanika Shanker, Md, MD
Pediatrics — Payments: $5,970
Mrs. Kristin Sabanosh, Rn Msn Cpnp, RN MSN CPNP
Pediatrics — Payments: $5,099
Dr. Tamara Mccluskey, Do, DO
Pediatrics — Payments: $3,387
Stephanie Schuckalo, Apn, APN
Pediatrics — Payments: $3,183
Dr. Gwyn Poblete, Md, MD
Pediatrics — Payments: $2,988